End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.16 CNY | +3.29% | +9.68% | -12.82% |
Business Summary
Number of employees: 8,325
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Distribution
33.1
%
| - | - | 3,989 | 33.1 % | - |
Anti-Infective Drugs
18.2
%
| 2,747 | 22.6 % | 2,192 | 18.2 % | -20.21% |
Cardiovascular Drugs
14.4
%
| 1,368 | 11.3 % | 1,734 | 14.4 % | +26.76% |
Anti-tumor Drugs
8.1
%
| 841 | 6.9 % | 972 | 8.1 % | +15.50% |
Import of Finished Drugs and Promotion of Imported Preparations
7.7
%
| - | - | 925 | 7.7 % | - |
Antiparasitic & Veterinary Drugs
7.6
%
| 892 | 7.3 % | 916 | 7.6 % | +2.77% |
Other Drugs
4.6
%
| 694 | 5.7 % | 558 | 4.6 % | -19.60% |
Endocrine Drugs
2.9
%
| 432 | 3.6 % | 350 | 2.9 % | -18.91% |
Other Business
2.7
%
| 234 | 1.9 % | 328 | 2.7 % | +40.19% |
CMO/CDMO/CRO
0.5
%
| - | - | 65 | 0.5 % | - |
Other
0.1
%
| 12 | 0.1 % | 8 | 0.1 % | -30.59% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
93.2
%
| 10,901 | 91.6 % | 10,910 | 93.2 % | +0.08% |
Foreign
6.8
%
| 1,001 | 8.4 % | 798 | 6.8 % | -20.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Qing Yang
CEO | Chief Executive Officer | - | 23-08-30 |
Jia Qiu Du
CHM | Chairman | 50 | 19-05-12 |
Wei Hong Xiao
PSD | President | 56 | 23-10-10 |
Shun Bing Yu
CHM | Chairman | 61 | - |
Xi Fei Shen
SEC | Corporate Secretary | 52 | 17-10-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shun Bing Yu
CHM | Chairman | 61 | - |
Jia Yi Zhao
BRD | Director/Board Member | 64 | 19-05-12 |
Li Rong Yang
BRD | Director/Board Member | 62 | 19-05-12 |
Rong Fu Fei
BRD | Director/Board Member | 39 | 18-01-18 |
Jia Qiu Du
CHM | Chairman | 50 | 19-05-12 |
Hua Li Zhou
BRD | Director/Board Member | 47 | 22-04-18 |
Bo Chao Zheng
BRD | Director/Board Member | 45 | 18-08-14 |
Junli Jin
BRD | Director/Board Member | 44 | 19-05-12 |
Hua Ping Zheng
BRD | Director/Board Member | 37 | 22-04-18 |
Xing Hu Shen
BRD | Director/Board Member | 53 | 23-08-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,263,530,275 | 680,523,114 ( 53.86 %) | 55,656,559 ( 4.405 %) | 53.86 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
10,191,200 | 0.93% | 10,843,437 $ |
Company contact information
Zhejiang Hisun Pharmaceutical Co., Ltd.
No. 46 Waisha Road Jiaojiang District
318000, Taizhou
+86 576 8882 7890
http://www.hisunpharm.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 1.34B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- 600267 Stock
- Company Zhejiang Hisun Pharmaceutical Co., Ltd.